Moreover, this induction was specific to TMZ, as another anti-glioma alkylating agent BCNU failed to promote IL8 expression in any GBM lines tested (***p < 0.001 and ****p < 0.0001, Fig. 1g). This evidence concerns the gene CXCL8 and glioblastoma.